The relationship between the apolipoprotein E e4 allele and hippocampal magnetic resonance imaging volume in community-dwelling individuals with mild Alzheimer's disease
- PMID: 30890889
- PMCID: PMC6065553
- DOI: 10.2147/DNND.S40835
The relationship between the apolipoprotein E e4 allele and hippocampal magnetic resonance imaging volume in community-dwelling individuals with mild Alzheimer's disease
Abstract
Background: The degree of hippocampal magnetic resonance imaging (MRI) volume loss in Alzheimer's disease (AD) is commonly accepted as a marker of disease severity, yet remains expensive, unavailable, or not tolerated by many patients.
Aim: To examine whether the presence of one or more apolipoprotein E (ApoE) e4 alleles is associated with smaller hippocampal MRI volumes in a population of early AD patients.
Methods: A total of 88 consecutive patients attending a community-based memory disorders clinic who had both mild dementia on the Clinical Dementia Rating scale and Diagnostic and Statistical Manual of Mental Disorders criteria for probable AD were recruited. We examined the relationship between ApoE e4 allele load and hippocampal atrophy on MRI volumes.
Results: There was no association between the ApoE e4 load and hippocampal volume in this cohort.
Conclusion: This study suggests that the presence of one or more ApoE e4 alleles cannot be used to estimate pathological disease load in early AD.
Keywords: Alzheimer’s disease; MRI; apolipoprotein E; hippocampus.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment.Arch Neurol. 2005 Jun;62(6):953-7. doi: 10.1001/archneur.62.6.953. Arch Neurol. 2005. PMID: 15956166 Clinical Trial.
-
Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.Neurology. 2001 Oct 23;57(8):1461-6. doi: 10.1212/wnl.57.8.1461. Neurology. 2001. PMID: 11673590
-
Applying surface-based hippocampal morphometry to study APOE-E4 allele dose effects in cognitively unimpaired subjects.Neuroimage Clin. 2019;22:101744. doi: 10.1016/j.nicl.2019.101744. Epub 2019 Mar 4. Neuroimage Clin. 2019. PMID: 30852398 Free PMC article.
-
The APOE ε4 variant and hippocampal atrophy in Alzheimer's disease and Lewy body dementia: a systematic review of magnetic resonance imaging studies and therapeutic relevance.Expert Rev Neurother. 2021 Aug;21(8):851-870. doi: 10.1080/14737175.2021.1956904. Epub 2021 Aug 13. Expert Rev Neurother. 2021. PMID: 34311631
-
APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.Alzheimers Dement. 2018 Sep;14(9):1137-1147. doi: 10.1016/j.jalz.2018.04.005. Epub 2018 May 18. Alzheimers Dement. 2018. PMID: 29782824 Clinical Trial.
References
-
- Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412–2414. - PubMed
-
- Baker R, Gholkar A, Scheltens P, et al. ApoE e4 allele, temporal lobe atrophy, and white matter lesions in late life dementias. Arch Neurol. 1999;56:961–965. - PubMed
-
- Geroldi C, Pihlajamäki M, Laakso M, et al. APOE-epsilon4 is associated with less frontal and more medial lobe atrophy in AD. Neurology. 1999;53:1825–1832. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous